Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7001
PUT
McEwen Inc
MUX
$1.25B
| $483K | ﹤0.01% |
38,030
-7,920
| -17% | -$112K |
|
7002
Ovid Therapeutics
OVID
$547M
| $483K | ﹤0.01% |
+116,335
| New | +$367K |
|
7003
PUT
Primerica
PRI
$8.94B
| $483K | ﹤0.01% |
3,700
-10,800
| -74% | -$1.39M |
|
7004
CALL
VanEck Steel ETF
SLX
$177M
| $483K | ﹤0.01% |
+12,800
| New | +$459K |
|
7005
CALL
Community Bank
CBU
$3.32B
| $482K | ﹤0.01% |
6,800
-700
| -9% | -$46.9K |
|
7006
PUT
Dorchester Minerals
DMLP
$1.41B
| $482K | ﹤0.01% |
24,700
+8,100
| +49% | +$145K |
|
|
ICAD
7007
DELISTED
iCAD Inc
ICAD
| $482K | ﹤0.01% |
+62,049
| New | +$443K |
|
|
MESO
7008
Mesoblast
MESO
$2.26B
| $482K | ﹤0.01% |
32,718
-6,836
| -17% | -$87.1K |
|
|
BFO
7009
DELISTED
Blackrock Florida Municipal 2020 Term Trust
BFO
| $482K | ﹤0.01% |
33,312
+14,355
| +76% | +$208K |
|
|
SLIM
7010
DELISTED
The Obesity ETF
SLIM
| $482K | ﹤0.01% |
12,526
-4,168
| -25% | -$151K |
|
7011
Dyadic International
DYAI
$24.6M
| $481K | ﹤0.01% |
+92,762
| New | +$556K |
|
7012
PUT
United Natural Foods
UNFI
$2.77B
| $481K | ﹤0.01% |
54,900
-146,200
| -73% | -$1.18M |
|
7013
DMC Global
BOOM
$141M
| $480K | ﹤0.01% |
10,689
+4,460
| +72% | +$198K |
|
7014
PUT
iShares US Pharmaceuticals ETF
IHE
$1.69B
| $480K | ﹤0.01% |
+9,000
| New | +$444K |
|
7015
National CineMedia
NCMI
$245M
| $480K | ﹤0.01% |
6,582
+3,730
| +131% | +$281K |
|
7016
CALL
RCI Hospitality Holdings
RICK
$231M
| $480K | ﹤0.01% |
23,400
-3,000
| -11% | -$57.8K |
|
|
UMPQ
7017
CALL
DELISTED
Umpqua Holdings Corp
UMPQ
| $480K | ﹤0.01% |
27,100
+9,000
| +50% | +$149K |
|
|
TERM
7018
DELISTED
EquityCompass Tactical Risk Manager ETF
TERM
| $480K | ﹤0.01% |
+25,184
| New | +$463K |
|
7019
Virtus Biotech Clinical Trials ETF
BBC
$50.6M
| $479K | ﹤0.01% |
+12,581
| New | +$374K |
|
7020
PUT
The Joint Corp
JYNT
$119M
| $479K | ﹤0.01% |
29,700
-8,400
| -22% | -$153K |
|
|
CHU
7021
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $479K | ﹤0.01% |
+51,129
| New | +$491K |
|
|
ALX
7022
Alexander's
ALX
$1.38B
| $478K | ﹤0.01% |
1,448
+335
| +30% | +$112K |
|
7023
PUT
Kinsale Capital Group
KNSL
$8.67B
| $478K | ﹤0.01% |
4,700
-2,000
| -30% | -$199K |
|
7024
PUT
Insight Enterprises
NSIT
$4.57B
| $478K | ﹤0.01% |
6,800
+3,000
| +79% | +$189K |
|
7025
Global X Cloud Computing ETF
CLOU
$383M
| $477K | ﹤0.01% |
30,261
-21,645
| -42% | -$329K |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.